Volume 33, Issue 3 - Clinical Trial Transparency and Disclosure
Navigating the complex landscape of clinical trial transparency: What medical writers need to know
Authors: Pooja Phogat, Stuart Donald
Abstract
Clinical trial transparency is beneficial for patients, researchers, and the general public. However, rapidly evolving regulatory requirements for transparency have increased the information that will be published. Medical writers can play a key role in driving compliance with applicable regulations. This paper provides an overview of transparency regulations and provides some points for medical writers to consider in this rapidly evolving area.
Medical Writing. 2024;33(3):26–33. https://doi.org/10.56012/timm8993
Download the full article
Visit the EMWA website
Search
Articles
Links
Editoral Board
Editor-in-Chief
Co-Editors
Managing Editor
Victoria White
Deputy Managing Editor
Alicia Brooks Waltman
Associate Editors
Section Editors
AI/Automation
Biotechnology
Digital Communication
EMWA News
Freelancing
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
Pablo Izquierdo / Alison McIntosh
In the Bookstores
Publications
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Louisa Ludwig-Begall / Sarah Kabani
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Layout Designer
Chris Monk